Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Securities Purchase Agreement [Member]
Statistical Measurement [Axis]
Maximum [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Loan and Security Agreement [Member]
Debt Instrument [Axis]
Tranche 1 [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Related and Nonrelated Parties [Axis]
Department of Veterans Affairs and Department of Defense [Member]
Contract with Customer, Sales Channel [Axis]
United States Rx [Member]
General Wellness [Member]
Outside The United States [Member]
T A C S T I M [Member]
In License Or Other [Member]
Product and Service [Axis]
Product [Member]
Geographical [Axis]
UNITED STATES
UNITED KINGDOM
Other Countries [Member]
License [Member]
JAPAN
2025 Finance Agreement [Member]
Long-Term Debt, Type [Axis]
Non-Convertible Notes Payable [Member]
Convertible Notes Payable [Member]
Tranche 2 [Member]
Minimum [Member]
Variable Rate [Axis]
Fixed plus Prime Rate [Member]
Subscription Agreement [Member]
Sales Agreement [Member]
Award Type [Axis]
Stock Purchase Warrants [Member]
Class of Warrant or Right [Axis]
Pre Funded Warrants [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock Units (RSUs) [Member]
Convertible Debt Securities [Member]
Warrant [Member]
Sale of Stock [Axis]
Employee Stock [Member]
Restricted Stock and Deferred Stock [Member]
Title and Position [Axis]
Non Employee Director [Member]
Restricted Stock [Member]
Income Location Balance [Axis]
Selling, General and Administrative [Member]
Research and Development [Member]
Cost of Goods and Services Sold [Member]
Exercise Price Range [Axis]
Exercise Price Range One [Member]
Exercise Price Range Two [Member]
Exercise Price Range Three [Member]
Segments [Axis]
Bioelectronic Innovations Segment [Member]
CVR Agreement [Member]
Vagus Nerve Society [Member]
Former Executive [Member]
Consulting Agreement [Member]
Board of Directors Chairman [Member]
Former Board Member [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets, net
Other assets, net
Total assets
Liabilities and Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Current portion of debt
Current portion of operating lease liabilities
Total current liabilities
Noncurrent liabilities:
Operating lease liabilities, noncurrent
Long-term debt
Total liabilities
Commitments and contingencies (see Note 15)
Stockholders’ deficit:
Common Stock, par value $0.001 per share; 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 8,125,613 shares issued and outstanding at March 31, 2026, and 8,004,416 shares issued and outstanding at December 31, 2025
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Total stockholders’ deficit
Total liabilities and stockholders’ deficit
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Net sales
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other (income) expense:
Interest and other income
Interest expense
Other expense
Total other expense
Loss before income taxes
Benefit from income taxes
Net loss
Net loss per share of common stock - Basic
Net loss per share of common stock - Diluted
Weighted average common shares outstanding - Basic
Weighted average common shares outstanding - Diluted
Net loss
Other comprehensive income:
Foreign currency translation adjustment
Other comprehensive loss
Comprehensive loss
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Other comprehensive loss
Options exercised
Options exercised, shares
Sale of common stock
Sale of common stock, shares
Equity issuance costs
Proceeds from the exercise of warrants
Proceeds from the exercise of warrants, shares
Shares issued for accrued bonus
Shares issued for accrued bonus, shares
Issuance of common stock in connection with employee stock plans, net of forfeitures
Issuance of common stock in connection with employee stock plans, net of forfeitures, shares
Share based compensation
Balances
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation
Depreciation and amortization
Amortization of right of use assets
Amortization of debt discount
Amortization of lease liability
Inventory reserve charge
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued expense and other current liabilities
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Sale of marketable securities
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from exercise of warrants
Proceeds from exercise of options
Sale of common stock
Equity issuance costs
Net cash provided by financing activities
Effect of changes in exchange rates on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents – beginning of year
Cash and cash equivalents – end of period
Supplemental cash flows disclosures:
Proceeds from sale of state net operating losses
Interest paid
Supplemental schedule of noncash activity:
Bonuses settled through the issuance of common stock
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b51 Arrangement Adopted
Non-Rule 10b51 Arrangement Adopted
Adoption Date
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Liquidity Credit Risks And Going Concern
Liquidity, Credit Risks and Going Concern
Revenue from Contract with Customer [Abstract]
Revenue
Fair Value Disclosures [Abstract]
Fair Value Measurements
Inventory Disclosure [Abstract]
Inventory
Leases
Leases
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities
Debt Disclosure [Abstract]
Long-Term Debt
Equity [Abstract]
Shareholders’ Equity
Earnings Per Share [Abstract]
Net Loss Per Share
Income Tax Disclosure [Abstract]
Income Taxes
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation
Segment Reporting [Abstract]
Segment Reporting
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Related Party Transactions [Abstract]
Related Party Transactions
Basis of Presentation
Principles of Consolidation
Use of Estimates
Cash and Cash Equivalents
Marketable Securities
Recent Accounting Pronouncements
Schedule of Net Sales Disaggregated By Channel
Schedule of Net Sales Disaggregated By Geographic Market
Schedule of Inventories
Schedule of Operating Leases
Schedule of Future Lease Payments
Schedule of Accrued Expenses and Other Current Liabilities
Schedule of Notes Payable and Convertible Notes Payable
Schedule of Maturities of Long-term Debt
Schedule of Stock Purchase Warrants Outstanding
Schedule of Common Stock Equivalent from the Computation of Diluted Loss Per Share
Schedule of Stock Compensation Expenses
Schedule of Outstanding Stock Options
Schedule of Stock Options Outstanding and Exercisable
Schedule of Restricted and Deferred Stock Unit
Schedule of Operating Financial Segment
Number of wholly owned subsidiaries
Cash and Cash Equivalent
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Net losses
Net cash used in operating activities
Aggregate proceeds
Exercise of warrants
Weighted average exercise price
Additional exxercise of warrants
Marketable securities
Potential cash inflows from issuance of stock
Remaining value available for shares issuance
Potential securities held by non-affiliates, at fair value
Potential securities held by non-affiliates
Proceeds from issuance of shares
Sale of shares
Share price
Debt principal amount
Debt principal amount, issued
Concentration risk percentage
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Total Net Sales
Fair value of marketable securities
Raw materials
Work in process
Finished goods
Total inventory
Obsolete inventory reserve
Schedule Of Operating Leases
Operating leases:
Operating lease right of use assets
Operating lease liabilities:
Noncurrent operating lease liabilities
Total operating lease liabilities
Operating cash flows
Weighted average remaining lease term (in years)
Weighted average discount rate
Schedule Of Future Lease Payments
Remainder of 2026
2027
2028
2029
2030
2031 and thereafter
Total future minimum lease payments
Less: Amounts representing interest
Total
Lease expenses
Accrued professional fees
Accrued bonuses and incentive compensation
Accrued litigation legal fees expense
Accrued insurance expense
Accrued research and development expenses
Accrued vacation and other employee related expenses
Accrued tax expenses
Accrued purchases of inventory
Deferred revenue
Accrued acquisition related expenses
Other
Accrued expenses and other current liabilities
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt Instrument, Face Amount
Debt term
Annual Interest rate
Periodic payments
Interest expense
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Principal Borrowed
Final Payment (3.50%)
Total Principal
Aggregate Debt Discount
Debt Discount Amortization
Unamortized Debt Discount
Long-Term Debt
Less: Current Portion of Debt
Long-Term Debt
Future payment debt amortization percentage
Remainder of 2026
2027
2028
2029
Total
Debt principal amount
Additional term loan
Debt Maturity date
Debt conversion converted instrument, amount
Debt conversion price per share
Debt conversion price, percentage
Closing stock price
Debt interest rate, percentage
Payments for term loans
Debt instrument, description
Debt instrument, unamortized discount
Debt issuance costs settled in shares
Interest Expense, debt
Potential cash in flows from issuance of stock
Share issued
Share issued, value
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Number of Warrants, outstanding beginning
Weighted Average Exercise Price, beginning balance
Weighted Average Remaining Contractual Term
Aggregate Intrinsic Value, beginning balance
Number of Warrants, Stock purchase warrants granted
Number of Warrants, Exercised
Weighted Average Exercise Price, Exercised
Number of Warrants, Expired
Number of Warrants, outstanding beginning
Weighted Average Exercise Price, beginning balance
Aggregate Intrinsic Value, beginning balance
Number of Warrants, outstanding
Weighted Average Exercise Price, exercisable
Aggregate Intrinsic Value, exercisable
Incremental common shares attributable to dilutive effect of call options and warrants
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock aggregate offering price under agreement
Issuance of costs
Stock issued during the period, shares
Stock issued during the period, value
Additional exxercise of warrants
Number of warrants exercised
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
IncomeLocationBalanceAxis [Axis]
Total expense
Number of Options, Outstanding, Beginning
Weighted Average Exercise Price, Outstanding, Beginning
Weighted Average Remaining Contractual Term, Outstanding
Aggregate Intrinsic Value, Outstanding, Beginning
Number of Options, Outstanding, Granted
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Cancelled
Number of Options, Expired
Number of Options, Outstanding, Ending
Weighted Average Exercise Price, Outstanding, Ending
Aggregate Intrinsic Value, Outstanding, Ending
Number of Options, Exercisable
Weighted Average Exercise Price, Exercisable
Weighted Average Remaining Contractual Term, Exercisable
Aggregate Intrinsic Value, Exercisable
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price, lower range limit
Exercise price, upper range limit
Options outstanding
Options outstanding weighted average remaining contractual life (Years)
Options exercisable
Number of Shares Nonvested Beginning
Number of Shares Nonvested Granted
Weighted Average Grant Date Fair Value - Granted
Number of Shares Nonvested Vested
Weighted Average Grant Date Fair Value - Vested
Number of Shares Nonvested Cancelled
Weighted Average Grant Date Fair Value - Cancelled
Number of Shares Nonvested Ending
Stock reserved for future issuance
Unrecognized compensation cost
Unrecognized compensation expected to be recognized
Vesting period
Vesting service period
Number of restricted stock units modified
Incremental stock compensation expense
Segment Reporting [Table]
Segment Reporting [Line Items]
Gross profit
Variable sales and marketing
Fixed sales and marketing
General and administrative
Total operating expenses
Loss from operations
Number of reportable segments
Severance liability
Description related to acquisition agreement
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Aggregate expenses
Consulting fees
Stock option granted
Exercise price
Liquidity credit risks and going concern disclosure [Text Block]
Securities Purchase Agreement [Member]
Potential cash inflows from issuance of stock.
Potential securities held by non affiliates at fair value.
Potential securities held by non affiliates.
Remaining value available for shares issuance.
Loan and Security Agreement [Member]
Tranche 1 [Member]
Department of Veterans Affairs and Department of Defense [Member]
Stock issued during period value warrants exercised.
Stock issued during period shares warrants exercised.
Schedule of Supplemental Balance Sheet Information for Operating Leases [Table Text Block]
Lessee operating lease liability payments due after year four.
Payments for proceeds from sale and maturity of marketable securities.
Proceeds from sale of state net operating losses.
Bonuses settled through issuance of common stock.
Amortization of operating lease liability.
Number of wholly owned subsidiaries.
Accrued legal fees litigation expense current.
Accrued research and development expenses current.
Accrued purchases.
Accrued acquisition related expenses.
2025 Finance Agreement [Member]
Non-Convertible Notes Payable [Member]
Aggregate debt discount amount.
Long terms debt.
Less current portion of debt.
Total debt, inclusive of long term and Current.
Additional term loan.
Tranche 2 [Member]
Debt instrument future payment debt amortization percentage.
Debt issuance costs settled in shares.
Subscription Agreement [Member]
Sales Agreement [Member]
CVR Agreement [Member]
Vagus Nerve Society [Member]
Consulting Agreement [Member]
Stock Purchase Warrants [Member]
Share based compensation arrangement by share based payment award equity instruments other than options exercised in period weighted average grant date fair value
Share based compensation arrangement by share based payment award non option equity instruments expired
Share based compensation arrangement by share based payment award non option equity instruments exercisable
Share based compensation arrangement by share based payment award equity instruments other than options exercisable in period weighted average grant date fair value
Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value exercisable
Pre Funded Warrants [Member]
Exercise Price Range One [Member]
Exercise Price Range Two [Member]
Exercise Price Range Three [Member]
Restricted Stock and Deferred Stock [Member]
Non Employee Director [Member]
Fixed sales and marketing.
Other Countries [Member]
Debt discount amortization.
Number of warrants exercised.
Stock issued during period value potential equity.
Selling, General and Administrative [Member]
Cost of Goods and Services Sold [Member]
Research and Development [Member]
Common stock aggregate offering price under agreement.
Number of restricted stock units modified.
Fixed plus Prime Rate [Member]
Assets, Current
Assets [Default Label]
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity [Default Label]
Interest and Other Income
Other Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Proceeds from Other Equity
Payments of Debt Issuance Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect, Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Lessee, Operating Leases [Text Block]
Cash, Cash Equivalents, and Short-Term Investments
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Interest Expense, Operating and Nonoperating
Debt Instrument, Unamortized Discount
LongTermsDebtCurrent
LongTermsDebt
Long-Term Debt, Maturity, Remainder of Fiscal Year
Long-Term Debt, Maturity, Year One
Long-Term Debt, Maturity, Year Two
Long-Term Debt, Maturity, Year Three
Long-Term Debt [Default Label]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Share based compensation arrangement by share based payment award non option equity instruments exercisable
Share based compensation arrangement by share based payment award equity instruments other than options exercisable in period weighted average grant date fair value
Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period